1. A8.1 Tristetraprolin is a novel therapeutic target for rheumatoid arthritis. (13th February 2015) Authors: Ross, EA; Smallie, T; Naylor, AJ; Desanti, GE; Crowe, J; O'Neil, JD; Turner, JD; Yemm, A; Norling, LV; Perlman, H; Verrills, NM; Filer, A; Dean, JL; Buckley, CD; Clark, AR Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗